Kelly Scheu
Impact in
- Gastroenterology top 5%
- Gastrointestinal Tumor Research and Treatment
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
Papers in
-
- Sarcoma Diagnosis and Treatment 5
- Gastric Cancer Management and Outcomes 1
- Oncology 6
- Vascular Tumors and Angiosarcomas 4
- Cancer Immunotherapy and Biomarkers 1
- Cancer Treatment and Pharmacology 1
- Co-authors
- Robert G. Maki (8 shared papers)Gary K. Schwartz (4 shared papers)David R. D’Adamo (5 shared papers)Martin Fleisher (1 shared paper)Suzanne Chanel (1 shared paper)Nicholas Sauter (1 shared paper)Ellin Berman (1 shared paper)Glenn Heller (1 shared paper)
- Journals
- Journal of Clinical Oncology (6 papers)Cancer (1 paper)Cancer Medicine (1 paper)New England Journal of Medicine (1 paper)Sarcoma (1 paper)
- Partner nations
- United States
In The Last Decade
Kelly Scheu
9 papers receiving 704 citations
Peers
Comparison fields: 5 of 57
- Gastroenterology 94
- Hematology 178
- Oncology 389
- Pulmonary and Respiratory Medicine 359
- Genetics 96
Countries citing papers authored by Kelly Scheu
This map shows the geographic impact of Kelly Scheu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly Scheu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly Scheu more than expected).
Fields of papers citing papers by Kelly Scheu
This network shows the impact of papers produced by Kelly Scheu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly Scheu. The network helps show where Kelly Scheu may publish in the future.
Co-authors
The 25 scholars most cited alongside Kelly Scheu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 217 | |
| 2 | 2005 | 200 | |
| 3 | 2013 | 148 | |
| 4 | 2005 | 83 | |
| 5 | 2005 | 66 | |
| 6 | 2006 | 3 | |
| 7 | 2025 | 2 | |
| 8 | 2004 | 2 | |
| 9 | 2024 | 1 | |
| 10 | 2004 | 1 |
About Kelly Scheu
Kelly Scheu is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Hematology, Cardiology and Cardiovascular Medicine and Pharmacology, having authored 10 papers that have together received 723 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (5 papers), Vascular Tumors and Angiosarcomas (4 papers), Cardiac tumors and thrombi (2 papers), Cancer Immunotherapy and Biomarkers (1 paper), Cancer Treatment and Pharmacology (1 paper), Gastric Cancer Management and Outcomes (1 paper), Myeloproliferative Neoplasms: Diagnosis and Treatment (1 paper) and Chronic Myeloid Leukemia Treatments (1 paper). The work is most often cited by research in Gastroenterology (94 citations), Hematology (178 citations), Oncology (389 citations), Pulmonary and Respiratory Medicine (359 citations) and Genetics (96 citations). Kelly Scheu has collaborated with scholars based in United States. Frequent co-authors include Robert G. Maki, Gary K. Schwartz, David R. D’Adamo, Martin Fleisher, Suzanne Chanel, Nicholas Sauter, Ellin Berman, Glenn Heller, Karen Albritton and Elyn Riedel. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Cancer Medicine, New England Journal of Medicine and Sarcoma.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.